Post on 30-May-2018
8/9/2019 Molecular Based Medicine
1/54
Molecular based (Molecular based (i.e, personalizedi.e, personalized))
MedicineMedicine
By I&C President Ryan WittBy I&C President Ryan Witt
witt.rj@gmail.comwitt.rj@gmail.com
8/9/2019 Molecular Based Medicine
2/54
ScheduleSchedule
Bio 101Bio 101
Molecular MedicineMolecular Medicine
8/9/2019 Molecular Based Medicine
3/54
RememberRemember
AskAskQQss
AlwaysAlwaysask Why/how, What, and Whenask Why/how, What, and When
Try toTry to understand EVERYTHING!nderstand EVERYTHING!
8/9/2019 Molecular Based Medicine
4/54
Our BodiesOur Bodies Made up of 10 to 100 trillionMade up of 10 to 100 trillion cellscells
CellsCells makemake upupTissuesTissues
Tissues makeTissues make OrgansOrgans
(i.e., Skin, lungs, brain)
8/9/2019 Molecular Based Medicine
5/54
MoleculesMolecules SoSo whatwhat andand wherewhere are molecules?are molecules?
What:What: A group ofA group oftwo or more atomstwo or more atoms bonded to onebonded to one
anotheranother.. ((Pauling, Linus (1970).Pauling, Linus (1970). General ChemistryGeneral Chemistry. New York: Dover Publications, Inc... New York: Dover Publications, Inc.. ISBNISBN 00--486486--6562265622--55 ))
WhereWhere: Everywhere: Everywhere IncludingIncluding insideinside ANDAND outsideoutside of cellsof cellsH20Water
8/9/2019 Molecular Based Medicine
6/54
Now, lets look atNow, lets look at
functionfunction
8/9/2019 Molecular Based Medicine
7/54
The DriverThe Driver
Molecules are the drivers of your cells.Molecules are the drivers of your cells.
Forming the structure ofForming the structure ofDNADNA, RNA, proteins,, RNA, proteins,enzymes, and EVERYTHING pushing our body toenzymes, and EVERYTHING pushing our body todo what it does!do what it does!
8/9/2019 Molecular Based Medicine
8/54
Proteins
Newly discovered / other components:Methylases (methylate DNA), mRNA, alternative splicing, micro-RNA, tRNA
8/9/2019 Molecular Based Medicine
9/54
DNADNA
Been called the Master Plan and yourBeen called the Master Plan and yourdestiny.destiny. Is there merit?Is there merit?
Codes for ALL playersCodes for ALL players proteins, enzymes, microRNA, RNA, etc.proteins, enzymes, microRNA, RNA, etc.
But, DNA is the code not an actor / player itselfBut, DNA is the code not an actor / player itself
8/9/2019 Molecular Based Medicine
10/54
Reality 101Reality 101
DNADNAisntisnteverything!everything! DNA mutations change our DNADNA mutations change our DNAthroughout our lifetimethroughout our lifetime++ Expression and function is partially independent of DNA (i.e., epigeneticsExpression and function is partially independent of DNA (i.e., epigenetics
(methylation); post(methylation); post--translational modifications)translational modifications) Expression and endExpression and end--conformation of molecules is what matters mostconformation of molecules is what matters most ---- that is,that is, whatwhat
playersplayers (i.e., RNA, glycoproteins, proteins)(i.e., RNA, glycoproteins, proteins) will bewill be active, and how are they functioningactive, and how are they functioning..
8/9/2019 Molecular Based Medicine
11/54
3 fun examples of environment/our actions +3 fun examples of environment/our actions +
DNA, and their results!DNA, and their results!
8/9/2019 Molecular Based Medicine
12/54
Example: Stubbing your ToeExample: Stubbing your Toe
(DNAchange)(DNAchange)
+
Rubbing
You can either rub or not! Depending on which affects the
molecular characteristics describing you in a diff t way!
8/9/2019 Molecular Based Medicine
13/54
Ex: form of DietingEx: form of Dieting
(methylation change)(methylation change) Excessive alcohol consumption has beenExcessive alcohol consumption has been
shown to alter DNA methylation in the colon ofshown to alter DNA methylation in the colon of
humans.humans.
8/9/2019 Molecular Based Medicine
14/54
Lights Effect:Lights Effect:VisionVision
(nothing to DNA; only protein changes)(nothing to DNA; only protein changes)
8/9/2019 Molecular Based Medicine
15/54
Lights Effect:Lights Effect:VisionVision
(nothing to DNA; only protein changes)(nothing to DNA; only protein changes)
8/9/2019 Molecular Based Medicine
16/54
In our BRAINS too!In our BRAINS too!
Technology is not only changing our lives, its changingTechnology is not only changing our lives, its changingour BRAINS.our BRAINS.
-- Dr Gary Small, Director of the UCLA Center on Aging & Professor ofDr Gary Small, Director of the UCLA Center on Aging & Professor ofPsychiatry and Behavioral Sciences at UCLAPsychiatry and Behavioral Sciences at UCLA
8/9/2019 Molecular Based Medicine
17/54
Coming back to the QComing back to the Q
Is our DNA everything?Is our DNA everything?
Our actions change our molecules, whichOur actions change our molecules, whichchange our cells, organs, and bodies!change our cells, organs, and bodies!
8/9/2019 Molecular Based Medicine
18/54
RealityReality
Reality isReality is
We are a product ofWe are a product ofenvironmentenvironment // actionsactions plus ourplus ourblueprintblueprint..
The blueprint is the start; everything from there isThe blueprint is the start; everything from there isup to you!up to you!
8/9/2019 Molecular Based Medicine
19/54
L
astlyL
astlyBeware!Beware!
ALWAYSALWAYSask, What, Why, When and Howask, What, Why, When and Howhttp://www.youtube.com/watch?v=R34Sguwxe2ohttp://www.youtube.com/watch?v=R34Sguwxe2o
8/9/2019 Molecular Based Medicine
20/54
44--
slideR
ecapslideR
ecap
8/9/2019 Molecular Based Medicine
21/54
MoleculesMolecules
Two or more atoms bound together!Two or more atoms bound together!
Molecules make up the components of cells,Molecules make up the components of cells,
tissue, organs, and us as a wholetissue, organs, and us as a whole
8/9/2019 Molecular Based Medicine
22/54
How your body worksHow your body works
8/9/2019 Molecular Based Medicine
23/54
Our actions affect our bodiesOur actions affect our bodies ----
at the molecular levelat the molecular level
Rubbing
8/9/2019 Molecular Based Medicine
24/54
Take Home PointsTake Home Points
1.1. Our actionsOur actions the molecular attributes describing thosethe molecular attributes describing thoseactions.actions.
2.2. Blueprint / cards dealt (DNA) + choices and environmentBlueprint / cards dealt (DNA) + choices and environment
3.3. Expression levels, the sequences of molecules, among otherExpression levels, the sequences of molecules, among other
factorsfactorswhich constantly are changingwhich constantly are changingare the keys toare the keys tounderstandingunderstanding the underlying molecular mechanismsthe underlying molecular mechanismsdescribing our actionsdescribing our actions, at any given moment., at any given moment.
(DNA is code, not the actor!)(DNA is code, not the actor!)
1 & 3 are VERY important for next lecture know them well!
8/9/2019 Molecular Based Medicine
25/54
COOL!COOL!
WoooooooooooooooofWoooooooooooooooof -- done! (next isdone! (next is
Medicine!)Medicine!)
Any questions?Any questions?
8/9/2019 Molecular Based Medicine
26/54
BreakBreak
Ask your doc about molecular testing if you have aAsk your doc about molecular testing if you have adisease, infection, or simply want to learn more aboutdisease, infection, or simply want to learn more aboutyourself.yourself.
What to testWhat to test ----
DNADNA
Expression levels, sequence, and functionality ofExpression levels, sequence, and functionality of
molecules (DNA
, micromolecules (DNA
, micro--RNA
, RNA
, proteins, etc)RNA
, RNA
, proteins, etc)
8/9/2019 Molecular Based Medicine
27/54
Break:Break: Myths about Genetic TestingMyths about Genetic Testing
and Molecular Medand Molecular Med1.1. Insurers can drop you based on results.Insurers can drop you based on results.
GINA prohibitsGINA prohibits ----
1.1. Denying coverageDenying coverage to a healthy individualto a healthy individual or chargingor chargingthat personthat person higherhigherpremiumspremiums based solely on abased solely on a genetic predispositiongenetic predisposition to developing a diseaseto developing a diseasein the future.in the future.
2.2. EmployersEmployers fromfrom usingusingindividuals'individuals' genetic information whengenetic information whenmakingmakinghiring,hiring, firing, job placement, orfiring, job placement, or promotionpromotion decisionsdecisions..
3.3. prohibits health insurers from using genetic information toprohibits health insurers from using genetic information todetermine eligibility or premiums, prohibits insurers and employersdetermine eligibility or premiums, prohibits insurers and employersfrom requesting or requiring that a person undergo a genetic test,from requesting or requiring that a person undergo a genetic test,and prohibits employers from using genetic information to makeand prohibits employers from using genetic information to make
employment decisions.employment decisions. AMA siteAMA site
2.2. If someoneIf someone diddidhappen to get a hold of my DNA, they could clone anhappen to get a hold of my DNA, they could clone anidentical copy of meidentical copy of me!!
8/9/2019 Molecular Based Medicine
28/54
MedicineMedicine
(the standard, then(the standard, then
innovation)innovation)
8/9/2019 Molecular Based Medicine
29/54
Key pointKey point
There areThere are
Our actions and
characteristics
the Molecules describing them&
Rubbing
Rubbing
8/9/2019 Molecular Based Medicine
30/54
Things can get very hazyThings can get very hazy
Cancer
8/9/2019 Molecular Based Medicine
31/54
MedicineMedicine
When it comes to medicine, challenge isWhen it comes to medicine, challenge is
Clinical SymptomsClinical Symptoms Where & What isWhere & What ismolecularmolecular--CauseCause
Stuffy nose
Fever
Headache
Slurred speech
Twitchy eye
8/9/2019 Molecular Based Medicine
32/54
Medical Diagnostics:Medical Diagnostics:
standard / currentlystandard / currently Differential diagnosisDifferential diagnosis
1.1. What is the most likely causeWhat is the most likely cause
2.2. Physical ExaminationPhysical Examination checking your signs andchecking your signs andsymptomssymptoms
3.3. Imaging Tools (MRIs, CT scans, fMRI, etc)Imaging Tools (MRIs, CT scans, fMRI, etc)
4.4. HistopathologyHistopathology looking under a microscope tolooking under a microscope todistinguish cell / tissue characteristicsdistinguish cell / tissue characteristics
8/9/2019 Molecular Based Medicine
33/54
TreatmentTreatment
Treatment by Treatment by trialtrial--andand--errorerror and and oneone--sizesize--fitsfits
allall
AMA and medical terminologyAMA and medical terminology
8/9/2019 Molecular Based Medicine
34/54
RightRightnownow
Many of the same diseases byMany of the same diseases bymodern classificationmodern classificationhavehave differentdifferent
molecular characteristics/driversmolecular characteristics/drivers..
Meaning:Meaning:NSCLC of squamousNSCLC of squamous typetype >>MDM2 mutationMDM2 mutation? p53? p53
mutation? And/or EGFR mt? Met? Etc.mutation? And/or EGFR mt? Met? Etc.
Picture Source:http://www.iftheshoefitz.com/
8/9/2019 Molecular Based Medicine
35/54
InnovationInnovation(Currently, not the standard)(Currently, not the standard)
8/9/2019 Molecular Based Medicine
36/54
BUTBUT
Wait a minute!Wait a minute!
What about the molecular drivers?What about the molecular drivers?
8/9/2019 Molecular Based Medicine
37/54
Molecular ProfilingMolecular Profiling
Now we have the capability toNow we have the capability to
take a sample of diseased or infected cells (or a persons normaltake a sample of diseased or infected cells (or a persons normalcells), andcells), and examine it at the molecular levelexamine it at the molecular level ---- looking at RNA,looking at RNA,protein structure, expression levels, and genetic makeup (DNA).protein structure, expression levels, and genetic makeup (DNA).
The methods are there (immunohistochemistry, DNA arrays,The methods are there (immunohistochemistry, DNA arrays,RNA microarrays, realRNA microarrays, real--time quantitative PCR)time quantitative PCR) Which is bestWhich is best unsureunsure!!
8/9/2019 Molecular Based Medicine
38/54
Cool! Whats the value?Cool! Whats the value?
Predictive to suggest treatment? Nonot byPredictive to suggest treatment? Nonot by
itself (if no clinical experiments are performed)itself (if no clinical experiments are performed)I.e., MammaPrint, EGFR test, Tissue of OriginI.e., MammaPrint, EGFR test, Tissue of Origin
But itBut it couldbecouldbe(predictive), if inferences are made(predictive), if inferences are made
by some personby some person(as you will see)(as you will see)
8/9/2019 Molecular Based Medicine
39/54
Profiling provides insights into the molecularProfiling provides insights into the molecular
mechanisms governing/describing yourmechanisms governing/describing yoursymptomssymptoms ---- AKAAKA
Knowledge!!!!!Knowledge!!!!!
8/9/2019 Molecular Based Medicine
40/54
What can be done with knowledge:What can be done with knowledge:Applying Molecular Profiling to TreatmentApplying Molecular Profiling to Treatment
CANCERCANCER
XelodaXeloda Thymidine Phosphorylase overexpressionThymidine Phosphorylase overexpression
EGFREGFR&& METMET overexpressionoverexpression
FUS1FUS1,, MDM2MDM2, &, & P53P53 therapytherapy
8/9/2019 Molecular Based Medicine
41/54
FUS1FUS1,, MDM2MDM2, &, & P53P53 therapytherapy
8/9/2019 Molecular Based Medicine
42/54
Application is to ALL diseasesApplication is to ALL diseases
With every ailment, there are respective proteins, genes, and molecules driving itsWith every ailment, there are respective proteins, genes, and molecules driving itsprogression.progression.
Bacterial InfectionsBacterial Infections
AzithromycinAzithromycin antibiotic; works on various strains of bacteria (antibiotic; works on various strains of bacteria (inhibits 50Sinhibits 50Sribosomal subunit from actingribosomal subunit from acting))
ALSALS
SOD1 geneSOD1 gene targettarget ---- ArimoclomolArimoclomol
AlzheimersAlzheimers,, MSMS,, ParkinsonsParkinsons, Crohns, Lupus, Crohns, Lupus
8/9/2019 Molecular Based Medicine
43/54
ValueValue
By seeing aBy seeing a comprehensive picturecomprehensive picture of ones expression levels,of ones expression levels,
sequences, and so forth, one hassequences, and so forth, one has a more clear viewa more clear viewof theof the
underlying molecules and structure of molecules, henceunderlying molecules and structure of molecules, hence a morea more
clear perspective on the likely outcomes of a therapeuticclear perspective on the likely outcomes of a therapeutic
intervention.intervention.
8/9/2019 Molecular Based Medicine
44/54
KnowledgeKnowledge
NearlyNearlyevery drug approved on the market by a regulatoryagency has a known molecularmode of action.
If you distinguish the molecular characteristics of a diseasefrom normal cell characteristics, then you can match drugs
perfectly with those disease characteristics and knownmolecular signaling pathways within a disease!
Hence, less of a trialHence, less of a trial--andand--error / oneerror / one--sizesize--fitsfits--all approach.all approach.
Idea that fuels (i) Molecular Medicine, (ii) Personalized Med,(iii) Combination Therapies and (iii) Drug Repositioning
8/9/2019 Molecular Based Medicine
45/54
Without molecular knowledge,Without molecular knowledge,
and continued trialand continued trial--
byby--
error Rx
error Rx
W/o mDx, you haveW/o mDx, you have ----
a)a) DifferentDifferent responses to the same treatments, in regards toresponses to the same treatments, in regards to
the safety and effectiveness of that therapy.the safety and effectiveness of that therapy.
http:
//learn.genetics.utah.edu/content/health/pharma/intro/http:
//learn.genetics.utah.edu/content/health/pharma/intro/
Life?Death?
8/9/2019 Molecular Based Medicine
46/54
W/o molecular testing and treatmentW/o molecular testing and treatment
b)b) Resistance Development & your Window ofResistance Development & your Window of
Opportunity isOpportunity is lost!lost!
1.1. Personal levelPersonal level
2.2. Society at largeSociety at large
8/9/2019 Molecular Based Medicine
47/54
Translation, PleaseTranslation, Please
W/o molecular profiling and continued trialW/o molecular profiling and continued trial--byby--errorerrortreatmenttreatment ----
1.1. Therapies available are no longer effective;Therapies available are no longer effective; must findmust find
something elsesomething else.. AntibioticsAntibiotics
2.2. Not everything is available nowNot everything is available now avg new canceravg new cancertherapy takes 14 yrs of testing before final approval.therapy takes 14 yrs of testing before final approval.
3
.3
. In the instance of antibiotic resistance and infectiousIn the instance of antibiotic resistance and infectiousdiseases, this means spreading these adverse effects todiseases, this means spreading these adverse effects tosociety!society!
8/9/2019 Molecular Based Medicine
48/54
QuestionsQuestions
Any questions?Any questions?
(ask: HOW, WHY, WHAT, WHEN!)(ask: HOW, WHY, WHAT, WHEN!)
8/9/2019 Molecular Based Medicine
49/54
Benefits of mBenefits of m--based Medicinebased Medicine
a)a) More specific detection and classification of existingMore specific detection and classification of existingdiseases, leading to more accurate prognoses and earlierdiseases, leading to more accurate prognoses and earlierdetection.detection.
b)b) Predictive/predisposition tests and actionable things you canPredictive/predisposition tests and actionable things you can
do with such infodo with such infoc)c) Better idea of whatBetter idea of whatmolecularlymolecularlyto target and how toto target and how to
most effectively and efficiently treat a patient with amost effectively and efficiently treat a patient with aparticular illness or infection.particular illness or infection.
http://learn.genetics.utah.edu/content/health/pharma/intro/http://learn.genetics.utah.edu/content/health/pharma/intro/
Less adverse side effects from metabolism variants (PGx) via dosageLess adverse side effects from metabolism variants (PGx) via dosagevariations for difft patients, combination drug adverse reactions, and sidevariations for difft patients, combination drug adverse reactions, and sideeffects in generaleffects in general
Better idea of what will work, and gives u additional ideas of what to use asBetter idea of what will work, and gives u additional ideas of what to use asan Rxan Rx
8/9/2019 Molecular Based Medicine
50/54
Increasing Trends inIncreasing Trends in
MolecularT
estingMolecularT
esting Learning aboutLearning about #lungcancer#lungcancer mgmt trends. EGFRmgmt trends. EGFR
mut'n testing is up from 2mut'n testing is up from 2--3% to ~103% to ~10--12% from early12% from earlyto late 2009; should rise more in next yr.to late 2009; should rise more in next yr.
-- Tweet from Oncologist in Seattle, WA
.Tweet from Oncologist in Seattle, WA
. The biology of lung cancer differs from one patient toThe biology of lung cancer differs from one patient to
the next, depending on age and sex, according tothe next, depending on age and sex, according toscientists at Duke University Medical Center. Thescientists at Duke University Medical Center. Thefindings may help explain why certain groups offindings may help explain why certain groups of
patients do better than others, even though they appearpatients do better than others, even though they appearto have the same disease.to have the same disease.
-- http://www.brightsurf.com/t/52409/http://www.brightsurf.com/t/52409/
8/9/2019 Molecular Based Medicine
51/54
Myths about Genetic TestingMyths about Genetic Testing
and Molecular Medand Molecular Med1.1. Insurers can drop you based on results.Insurers can drop you based on results. GINA prohibitsGINA prohibits ----
1.1. Denying coverageDenying coverage to a healthy individualto a healthy individual or chargingor chargingthat personthat person higherhigherpremiumspremiums based solely on abased solely on a genetic predispositiongenetic predisposition to developing a diseaseto developing a diseasein the future.in the future.
2.2. EmployersEmployers fromfrom usingusingindividuals'individuals' genetic information whengenetic information whenmakingmakinghiring,hiring, firing, job placement, orfiring, job placement, or promotionpromotion decisionsdecisions..
3.3. prohibits health insurers from using genetic information toprohibits health insurers from using genetic information todetermine eligibility or premiums, prohibits insurers and employersdetermine eligibility or premiums, prohibits insurers and employersfrom requesting or requiring that a person undergo a genetic test,from requesting or requiring that a person undergo a genetic test,and prohibits employers from using genetic information to makeand prohibits employers from using genetic information to make
employment decisions.employment decisions. A
MA
siteA
MA
site
2.2. If someoneIf someone diddidhappen to get a hold of my DNA, they could clone anhappen to get a hold of my DNA, they could clone anidentical copy of meidentical copy of me!!
8/9/2019 Molecular Based Medicine
52/54
Where to go from hereWhere to go from here
Talk with your doc about molecular testing if you have a disease,Talk with your doc about molecular testing if you have a disease,infection, or simply want to learn more about yourself and theinfection, or simply want to learn more about yourself and theunderlying molecular mechanisms of your disease, infection orunderlying molecular mechanisms of your disease, infection orbiological actions.biological actions.
Molecular profiling, molecular testing, genetic testingMolecular profiling, molecular testing, genetic testing
What to testWhat to test ----
DNA
DNA
genetic testinggenetic testing Expression levels, sequence, and functionality of moleculesExpression levels, sequence, and functionality of molecules
(DNA, micro(DNA, micro--RNA, RNA, proteins, etc)RNA, RNA, proteins, etc) ---- molecular profilingmolecular profiling
8/9/2019 Molecular Based Medicine
53/54
What Are We (I&C) Doing?What Are We (I&C) Doing?
Bringing innovation to you at theBringing innovation to you at the fastest ratefastest rate
possiblepossible is our goal.is our goal.1.1. CommunityCommunity--based education and resource sharingbased education and resource sharing
2.2. Building an interface to empower you to make a differenceBuilding an interface to empower you to make a difference
3.3. Working to integrate these innovations and patient optionsWorking to integrate these innovations and patient options
into physicians workflow.into physicians workflow.
8/9/2019 Molecular Based Medicine
54/54
Why do we say this?Why do we say this?
(pharmacogenomics slide)(pharmacogenomics slide) WellWell ----have you ever wondered why you respondedhave you ever wondered why you responded
differently than your best friend to the SAMEdifferently than your best friend to the SAMEtreatment?treatment?thetheAnswer:Answer:
Diff genetic makeup and molecular expression expressionsDiff genetic makeup and molecular expression expressionsthan your friendthan your friend
Meaning, the things that break down the treatment in yourMeaning, the things that break down the treatment in yourbody are different as are those things that clear them frombody are different as are those things that clear them fromyour body, as are your molecular profiles in the cells you wishyour body, as are your molecular profiles in the cells you wishto target.to target.
HenceHence, we have effectiveness, we have effectiveness andandsafety differences!safety differences!